Half Yearly Report and Accounts
Key Metrics
Annual Recurring Revenue = $49.0m (+15.3% PCP)
Client sites = 391 (+16.0% PCP)
Statutory revenue = $26.8m (+13.8% PCP)
Gross profit = 48.4% (+16.6% PCP)
Adjusted EBITDA (loss) = $(2.0m) - Improved 44.9% PCP
Key Highlights
- Total revenue of $26,817k of which 80.5% is recurring, increased $3,252k (13.8%) over 1H FY21 (PCP) predominantly due to strong growth in project revenue in the America’s and strong Annual Recurring Revenue (ARR) sales over the prior 12 months converting into booked recurring revenue during the current reporting period.
- Gross profit (statutory) continues to improve with gross profit of 47.5%, showing steady growth from 44.0% in prior period and 40.6% in PCP.
- Operating expenses increased 7.0% over PCP as a result of investment in EVS Water, Product Development and transformation project costs including the transition from private data centres to AWS and a new ticketing system.
- Adjusted EBITDA loss of $1,964k represents a significant improvement over $3,562k loss in the PCP due to revenue growth. Adjusted EBITDA is lower than the prior period due to the additional operating expenses incurred in investing in EVS Water, Product Development and transformation project costs.
Strong ARR sales wins over the past 12 months in the America’s and EMEA have driven the increase in recurring revenue of $1,509k (7.5%) compared with PCP. Recurring revenues for the current reporting period were impacted by global supply issues causing delays in project implementations.
Revenue growth of $3,248k (13.8%) compared with the PCP included strong growth in non-recurring revenue (up 50.0% against PCP) mainly in the Americas within Omnis and Aviation. Revenues in Asia Pacific were lower in the current reporting period than in PCP, predominantly due to PCP including significant low margin non-recurring revenues in China that were not repeated in this current reporting period.
New Aviation sites won in the prior period drove an increase in Aviation recurring revenues of $1,085k against the PCP. Non-recurring Aviation revenue has also seen growth when compared to the PCP as the effects of COVID on the Aviation industry started to reduce and client project spend has started to increase
New Omnis sites won over the past 12 months have driven Omnis recurring revenues up $380k (6.6%) compared to the PCP, however the impact of these new sales wins was reduced due to supply chain issues impacting the delivery of instrumentation and associated revenue recognition. Non-recurring revenue in Omnis was significantly up on PCP (24.4%) due to material deals in the mining industry in South America.
While revenues from Water are minimal in the current reporting period, there have been significant new ARR sales wins during the current reporting period, with revenue expected to materially increase over the next 12 months.
EBITDA is a non-IRFS measure and is calculated by adding back depreciation, amortisation and interest from net loss before tax. Adjusted EBITDA also adds back share-based compensation expense, foreign currency gains and losses, and transaction and integration costs (which are seen as non-recurring) and excludes the impacts of adopting AASB 16, as the application of the standard results in operating expenses being excluded from EBITDA.
For the half-year ended 31 December 2021, the Group reported an Adjusted EBITDA loss of $1,964k, an improved result over the $3,562k loss incurred in the PCP due to strong revenue growth. Adjusted EBITDA was down on the prior period ended 30 June 2021 due to costs associated with investment in EVS Water, Product Development and transformation project costs.
Cash and Cash Equivalents increased by $6,074k during the current reporting period, predominantly due to a capital raise in December 2021 for $10,469k ($9,946k net of transaction costs) of additional equity to fund further expansion of EVS Water. The remaining decrease in cash related to:
- $1,562k from operating activities
- $1,087k cash used in the acquisition of intangible assets which relate to capitalised product development costs
- $800k in payments for Property, Plant and Equipment
- $423k other cashflows
Total cash used in operating activities when adding capitalised development costs and repayment of lease liabilities (“Adjusted Operating Cashflow”) was an outflow of $3,559k, this is down from $3,882k in the prior period and $5,064k in the PCP, showing consistent improvement in the cash management of the business.
The Group has a healthy balance sheet following the cash raised during the current financial period, the lack of debt on the balance sheet (other than lease liabilities) and the strong management of Adjusted EBITDA and operating cashflows during the period.
The Directors continue to monitor the impacts of the COVID-19 pandemic on group operations and respond appropriately to risks identified.